HomeComparePETQ vs EQR

PETQ vs EQR: Dividend Comparison 2026

PETQ yields 6.46% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQR wins by $17.2K in total portfolio value
10 years
PETQ
PETQ
● Live price
6.46%
Share price
$30.98
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.6K
Annual income
$973.55
Full PETQ calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — PETQ vs EQR

📍 EQR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPETQEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PETQ + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PETQ pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PETQ
Annual income on $10K today (after 15% tax)
$548.74/yr
After 10yr DRIP, annual income (after tax)
$827.52/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, EQR beats the other by $3,826.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PETQ + EQR for your $10,000?

PETQ: 50%EQR: 50%
100% EQR50/50100% PETQ
Portfolio after 10yr
$39.2K
Annual income
$3,224.58/yr
Blended yield
8.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

PETQ
No analyst data
Price Target
$31.00
+0.1% upside vs current
Range: $31.00 — $31.00
Altman Z
2.5
Piotroski
8/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PETQ buys
0
EQR buys
0
No recent congressional trades found for PETQ or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPETQEQR
Forward yield6.46%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$30.6K$47.8K
Annual income after 10y$973.55$5,475.61
Total dividends collected$8.1K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst price target$31.00$70.35

Year-by-year: PETQ vs EQR ($10,000, DRIP)

YearPETQ PortfolioPETQ Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$11,346$645.58$11,380$679.82$34.00EQR
2$12,824$684.53$13,014$837.25$190.00EQR
3$14,445$723.13$14,961$1,036.20$516.00EQR
4$16,218$761.23$17,297$1,289.22$1.1KEQR
5$18,151$798.73$20,121$1,613.15$2.0KEQR
6$20,258$835.49$23,561$2,030.84$3.3KEQR
7$22,547$871.43$27,783$2,573.54$5.2KEQR
8$25,032$906.47$33,013$3,284.39$8.0KEQR
9$27,725$940.52$39,547$4,223.51$11.8KEQR
10$30,639$973.55$47,791$5,475.61$17.2KEQR

PETQ vs EQR: Complete Analysis 2026

PETQStock

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

Full PETQ Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this PETQ vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PETQ vs SCHDPETQ vs JEPIPETQ vs OPETQ vs KOPETQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.